Genital infections due to the human papillomavirus

Enferm Infecc Microbiol Clin (Engl Ed). 2019 May;37(5):324-334. doi: 10.1016/j.eimc.2019.01.010. Epub 2019 Mar 8.
[Article in English, Spanish]

Abstract

The Human Papillomavirus (HPV) is a double-stranded DNA virus, with more than 200 different genotypes having been identified. This infection is considered the most common sexually transmitted infection (STI), and it is the cause of a significant number of diseases, both benign lesions (anogenital condylomas) and pre-malignant lesions and different cancers. The diagnosis of the infection is performed by molecular techniques based on the detection of viral DNA, the mRNA of oncogenic proteins and cellular alteration caused by the infection. Although there is no consensus regarding the best treatment, this should be individualised, and there are different options with ablative treatments being more effective but with greater recurrences, and immunomodulatory treatments being less effective in the short term but with fewer recurrences. Among the preventive strategies, vaccination against HPV is the best strategy against anogenital neoplasms and warts, its maximum effectiveness being when it is administered prior to exposure to HPV.

Keywords: Condiloma; Condyloma; Papillomavirus; Papilomavirus; Vaccines; Vacunas.

Publication types

  • Review

MeSH terms

  • Female
  • Genital Diseases, Female / diagnosis
  • Genital Diseases, Female / epidemiology
  • Genital Diseases, Female / therapy
  • Genital Diseases, Female / virology*
  • Genital Diseases, Male / diagnosis
  • Genital Diseases, Male / epidemiology
  • Genital Diseases, Male / therapy
  • Genital Diseases, Male / virology*
  • Humans
  • Male
  • Papillomaviridae / genetics
  • Papillomavirus Infections* / diagnosis
  • Papillomavirus Infections* / epidemiology
  • Papillomavirus Infections* / therapy
  • Practice Guidelines as Topic